Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-02-25 @ 4:49 PM
Study NCT ID:
NCT02166658
Status:
TERMINATED
Last Update Posted:
2018-01-23
First Post:
2014-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)
Sponsor:
AIO-Studien-gGmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
None
Primary Completion Date:
2017-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-16
First Submit QC Date:
None
Study First Post Date:
2014-06-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-19
Last Update Post Date:
2018-01-23
Last Update Post Date Type:
ACTUAL